Search
for
Sort by
Research 31–60 of 592
- The Implication of Neuroactive Steroids in Tourette's Syndrome Pathogenesis: A Role for 5α‐Reductase?
- Endocrine profile of the VCD-induced perimenopausal model rat
- Exploring the Impact of the Microbiome on Neuroactive Steroid Levels in Germ-Free Animals
- Prenatal Exposure to Delta-9-tetrahydrocannabinol (THC) Alters the Expression of miR-122-5p and Its Target Igf1r in the Adult Rat Ovary
- From male PCOS to male endocrine-metabolic syndrome: a gender-neutral hypothesis
- Characterization of DNA Methylation and Screening of Epigenetic Markers in Polycystic Ovary Syndrome
- The Neurosteroidogenic Enzyme 5α-Reductase Mediates Psychotic-Like Complications of Sleep Deprivation
- The 5α-reductase inhibitor finasteride reduces opioid self-administration in animal models of opioid use disorder
- Rare and Underappreciated Causes of Polycystic Ovarian Syndrome
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- Vitamin D receptor polymorphisms and the polycystic ovary syndrome: A systematic review
- Hyperandrogenism in polycystic ovary syndrome and adrenal hyperplasia: finding differences to make a specific diagnosis
- Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites
- Cutaneous Androgen Metabolism: Basic Research and Clinical Perspectives
- ATP-dependent chromatin remodeling during mammalian development
- Linking diet to acne metabolomics, inflammation, and comedogenesis: an update
- Polycystic ovary syndrome and impact on health
- Endocrinologic Aspects of Hidradenitis Suppurativa
- Adrenal Disorders and the Paediatric Brain: Pathophysiological Considerations and Clinical Implications
- Metabolism and skin diseases
- Role of Environmental Factors and Gonadotoxin Exposure in Unexplained Male Infertility
- The impact of obesity on the folliculosebaceous unit
- Gonadal Sex Steroids: Production, Action and Interactions in Mammals
- Therapeutic Potential of Vitex negundo for the Treatment of Polycystic Ovarian Disease (PCOD): A Review
- Pharmacokinetic and Therapeutic Dose Comparison of Diane-35 and IVF-C Inj 5000 IU in Common Quail
- Polycystic Ovarian Disease: Current Insights and therapeutic Strategies
- A Review: Proteins Involved in the Major Symptoms of Polycystic Ovarian Syndrome
- MENSTRUAL DISORDERS IN ADOLESCENTS
- 17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome
- Pharmacologic Treatment of Polycystic Ovary Syndrome